35.29
Schlusskurs vom Vortag:
$36.06
Offen:
$35.35
24-Stunden-Volumen:
113.09K
Relative Volume:
0.40
Marktkapitalisierung:
$1.57B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.77%
1M Leistung:
+18.62%
6M Leistung:
+162.13%
1J Leistung:
+0.00%
Sionna Therapeutics Inc Stock (SION) Company Profile
Firmenname
Sionna Therapeutics Inc
Sektor
Branche
Telefon
617-819-2020
Adresse
21 HICKORY DRIVE, SUITE 500, WALTHAM
Vergleichen Sie SION mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SION
Sionna Therapeutics Inc
|
35.60 | 1.59B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.79 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.16 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.78 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.97 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.06 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-03-04 | Eingeleitet | Guggenheim | Buy |
| 2025-03-04 | Eingeleitet | Stifel | Buy |
| 2025-03-04 | Eingeleitet | TD Cowen | Buy |
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
Sionna Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire
What Fibonacci levels say about Sionna Therapeutics Inc. reboundTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Will Sionna Therapeutics Inc. rebound enough to break evenJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
How analysts rate Sionna Therapeutics Inc. stock todayJuly 2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Will a bounce in Sionna Therapeutics Inc. offer an exitMarket Risk Report & Consistent Income Trade Recommendations - newser.com
What Wall Street predicts for Sionna Therapeutics Inc. stock priceTrade Risk Assessment & AI Powered Market Entry Ideas - newser.com
Is Sionna Therapeutics Inc. stock a safe buy before earningsJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
How to build a dashboard for Sionna Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Relative strength of Sionna Therapeutics Inc. in sector analysisGap Up & Breakout Confirmation Trade Signals - newser.com
Will Sionna Therapeutics Inc. stock go up soonEarnings Performance Report & Capital Efficiency Focused Ideas - newser.com
Can technical indicators confirm Sionna Therapeutics Inc.’s reversalMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Sionna Therapeutics Inc. stock chart pattern explainedJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
Is Sionna Therapeutics Inc. stock a safe haven assetChart Signals & Safe Capital Investment Plans - newser.com
Sionna Therapeutics, Inc. $SION Shares Sold by Jennison Associates LLC - MarketBeat
Why Sionna Therapeutics Inc. stock attracts global investorsTrade Ideas & Verified Technical Trade Signals - newser.com
Applying Wyckoff theory to Sionna Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Sionna Therapeutics Inc. stock trendline breakdown2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Sionna Therapeutics Advances Phase 1 Study for Cystic Fibrosis Treatment - TipRanks
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 62,610 Shares of Stock - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Director Sells $12,284,500.00 in Stock - MarketBeat
What analysts say about Sionna Therapeutics Inc stockVolume Analysis Techniques & Next-Level Stock Intelligence, Now Free - earlytimes.in
Should You Hold or Sell IMP Powers Limited Stock Expert PerspectivesSector-Based Investing & Small Entry Capital Stocks - earlytimes.in
Finanzdaten der Sionna Therapeutics Inc-Aktie (SION)
Es liegen keine Finanzdaten für Sionna Therapeutics Inc (SION) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Sionna Therapeutics Inc-Aktie (SION) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
39.58 |
62,610 |
2,478,104 |
209,391 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):